John P. Schmid, CFO and Secretary at Trius Therapeutics Inc (TSRX), sold 500 shares at $5.04 ($3K) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Scheduled sale ($3k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |